Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 19

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 19
---
 to close embodied in a “timing agreement” between the parties and a governmental body, and the receipt of regulatory approvals in other jurisdictions, including China and Japan among others. The following sentence is hereby added at the end of each of the third paragraph of the section titled “Proposal 1: Adoption of the Merger Agreement—Regulatory Approvals Required for the Merger—Required Regulatory Approvals” on page 76 of the proxy statement, the second paragraph of the section of the Summary titled “—Regulatory Approvals Required for the Merger” on page 5 of the proxy statement, the third bullet under the section titled “The Merger Agreement—Conditions to the Closing of the Merger” on page 93 of the proxy statement and the related section of the Summary on page 6 of the proxy statement, and the first full paragraph on page 24 of the proxy statement, under the risk factor titled “The consummation of the Merger is subject to certain closing conditions...”: As of the filing of this Supplement, STAAR has received all required regulatory approvals or confirmation that the applicable regulators have completed their review other than in China, Portugal and Turkey. (9) Supplements to “Proposal 1: The Adoption of the Merger Agreement” and “The Merger Agreement” The following section is added at the end of the section titled “The Merger Agreement” beginning on page 77 of the proxy statement. The Merger Agreement is attached as an exhibit to the proxy statement, the First Amendment was attached as Annex A to the November 17, 2025 proxy supplement, and the Second Amendment is attached as Annex A to this Supplement. 14

Second Amendment

On December 9, 2025, STAAR, Alcon and Merger Sub entered into the Second Amendment. The Second Amendment provides, among other things, for an increase in the merger consideration payable to holders of shares of STAAR common stock. Pursuant to the Second Amendment, each issued and outstanding share of STAAR common stock as of immediately prior to the Effective Time (other than Excluded Shares and Dissenting Shares) will be converted into the right to receive merger consideration of $30.75 per share in cash, without interest, subject to withholding of taxes. Prior to the entry into the Second Amendment, such holders of STAAR common stock would have received merger consideration of $28.00 per share in cash, without interest, subject to withholding of taxes.

In addition, the Second Amendment (i) provides that each STA